The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy

BACKGROUND AND OBJECTIVES: Biologic therapies are considered to be cost effective by leading Health Technology Assessment (HTA) agencies and, therefore, eligible for reimbursement by public health services. However, biologic therapies entail sizable incremental costs and, besides, have a considerabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Spandonaro, Federico, Ayala, Fabio, Berardesca, Enzo, Chimenti, Sergio, Girolomoni, Giampiero, Martini, Patrizia, Peserico, Andrea, Polistena, Barbara, Puglisi Guerra, Antonio, Vena, Gino Antonio, Altomare, Gianfranco, Calzavara Pinton, Piergiacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030097/
https://www.ncbi.nlm.nih.gov/pubmed/24567261
http://dx.doi.org/10.1007/s40259-014-0084-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030097/
https://www.ncbi.nlm.nih.gov/pubmed/24567261
http://dx.doi.org/10.1007/s40259-014-0084-3

Ejemplares similares